1-9 of 9
Concepción Nicolás
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of the Current Treatments on the Survival of Patients with Mantle Cell Lymphoma (MCL): A Real-Life Study on Behalf of the Spanish Group of Lymphoma (GELTAMO)

Ana Marin Niebla, Mariana Bastos-Oreiro, Alba Cabirta Touzón, Marta Canelo Vilaseca, Juan-Manuel Sancho, Ana Jimenez Ubieto, Adolfo Jesús Sáez Marín, Ana Garcia Noblejas, Pablo Prieto Martinez, Concepcion Nicolas, Carlos Grande Garcia, Hugo Daniel Luzardo Henriquez, Jose Angel Hernandez Rivas, Ana Muntanola, Rosalia Alonso Trillo, Irene Arnaiz, Eva Donato, Paola Villafuerte Gutierrez, Daniel Garcia Belmonte, Alicia Roldan Perez, Sandra Suarez Ordonez, Víctor Navarro Garces, Francesc Bosch, Pau Abrisqueta
Journal: Blood
Blood (2023) 142 (Supplement 1): 1678.
https://doi.org/10.1182/blood-2023-186101
Published: 2023
Journal Articles

Genetic Subtyping Using Whole Exome Sequencing across Large B Cell Lymphoma Entities in a Series of 109 DLBCL and Plasmablastic Lymphoma Cases

Santiago Montes-Moreno, Sr., Aitana Avendaño, Sonia Gonzalez De Villambrosia, Laura Rodriguez-Merino, Jordi Morata, Raul Tonda, Estrella Carrillo-Cruz, Carlos Grande, Jose Maria Roncero, Jaime Perez De Oteyza, Concepcion Nicolas, Beatriz Rey Búa, Pau Abrisqueta, Antonio Gutierrez, Angel Ramirez, Alejandro Martin Garcia-Sancho, Eva Maria Gonzalez Barca
Journal: Blood
Blood (2023) 142 (Supplement 1): 6092.
https://doi.org/10.1182/blood-2023-179150
Published: 2023
Journal Articles

Cell Free Tumor DNA for DLBCL Genotyping in a Phase II Randomized Trial Comparing Standard RCHOP Versus Brcap As First Line Treatment in Patients with Poor IPI DLBCL

Nerea Martinez, PhD, Sonia González de Villambrosia, MD, Ainara Pereña, Raul Tonda, Sergi Beltran, PhD, Marta Gut, PhD, Estrella Carrillo-Cruz, MD, Carlos Grande, MD, Alejandro Martín, MD, Concepcion Nicolas, MD, Jose Maria Roncero, MD, Maria J. Rodriguez-Salazar, MD, Jaime Perez De Oteyza, MDPhD, Eulogio Conde, MD PhD, Eva Gonzalez-Barca, Santiago Montes-Moreno, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1676.
https://doi.org/10.1182/blood-2018-99-113757
Published: 2018
Journal Articles

Long-term results of a phase 2 study of rituximab and bendamustine for mucosa-associated lymphoid tissue lymphoma

Clinical Trials & Observations
Antonio Salar, Eva Domingo-Domenech, Carlos Panizo, Concepción Nicolás, Joan Bargay, Ana Muntañola, Miguel Canales, José Luis Bello, Juan Manuel Sancho, José Francisco Tomás, María José Rodríguez, Javier Peñalver, Carlos Grande, José Javier Sánchez-Blanco, Luis Palomera, Reyes Arranz, Eulogio Conde, Mar García, Juan Fernando García, Dolores Caballero, Carlos Montalbán
Journal: Blood
Blood (2017) 130 (15): 1772–1774.
https://doi.org/10.1182/blood-2017-07-795302
Published: 2017
Journal Articles

Mutational Landscape, Clonal Evolution Patterns and Role of RAS Mutations in Relapsed Acute Lymphoblastic Leukemia

Koichi Oshima, MD PhD, Hossein Khiabanian, PhD, Ana Carolina da Silva Almeida, PhD, Gannie Tzoneva, PhD, Francesco Abate, PhD, Alberto Ambesi-Impiombato, MD PhD, Marta Sanchez-Martin, PhD, Zachary Carpenter, PhD, Alexander Penson, PhD, Arianne Perez-Garcia, PhD, Cornelia Eckert, PhD, Concepción Nicolás, MD, Milagros Balbin, Maria Luisa Sulis, MD, Motohiro Kato, MD PhD, Katsuyoshi Koh, MD, Maddalena Paganin, Giuseppe Basso, MD, Julie M. Gastier-Foster, PhD, Meenakshi Devidas, PhD, Mignon L. Loh, MD, Renate Kirschner-Schwabe, PhD, Teresa Palomero, PhD, Raul Rabadan, PhD, Adolfo A. Ferrando, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4068.
https://doi.org/10.1182/blood.V128.22.4068.4068
Published: 2016
Journal Articles

Phase 2 Randomized Trial Comparing Standard RCHOP Versus Brcap (bortezomib, rituximab, cyclophosphamide, adriamycin and prednisone) As First Line Treatment in Young Patients with High-Risk Diffuse Large B-Cell Lymphoma (DLBCL). a Study from Spanish Group Geltamo

Eva González-Barca, MD PhD, Estrella Carrillo-Cruz, MD, Carlos Grande, MD PhD, Alejandro Martín, MD PhD, Mónica Coronado, MD, Santiago Montes-Moreno, MD, Santiago Mercadal, MD, Josep Maria Roncero, MD, Jaime Pérez de Oteyza, MD, Concepción Nicolás, MD, María José Rodríguez-Salazar, MD, Juan-Manuel Sancho, Luis Palomera, MD PhD, Javier López-Jiménez, MD, Carmen Albo, MD, Francisco-Javier Peñalver, MD, José Ángel Hernández, MD, Armando López-Guillermo, MD PhD, María José Ramírez, MD, Isidro Jarque, MD, Joan Bargay, MD, Miguel Canales, MD PhD, Eulogio Conde, MD PhD, Dolores Caballero, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4201.
https://doi.org/10.1182/blood.V128.22.4201.4201
Published: 2016
Journal Articles

Phase 2 Randomized Trial Comparing 6 Cycles of Standard RCHOP Chemotherapy Vs 6 Cycles of Brcap (bortezomib, rituximab, cyclophosphamide, adriamicine and prednisone) As First Line Treatment in Young Patients with Poor Prognosis Diffuse Large B-Cell Lymphoma (DLBCL): Interim Analysis

Eva González-Barca, MD PhD, Estrella Carrillo, Carlos Grande, MD, Alejandro Martín, Mónica Coronado, Santiago Montes-Moreno, Jaime Perez de Oteyza, Concepción Nicolas, Juan-Manuel Sancho, Luis Palomera, MDPhD, Javier Lopez, Sr., MD PhD, Armando Lopez-Guillermo, Francisco Javier Peñalver, José Ángel Hernández, MD, Maria Jose Ramirez, Isidro Jarque, Joan Bargay, MD, Mª José Rodríguez, Miguel Canales, Carmen Albo, Maite Encuentra, Dolores Caballero
Journal: Blood
Blood (2015) 126 (23): 1514.
https://doi.org/10.1182/blood.V126.23.1514.1514
Published: 2015
Journal Articles

Outcome and Long Term Toxicity of the LNH- PRO Trial after 12 Year Median Follow-up, in Patients with Indolent Non Hodgkin's Lymphoma Who Received Immunochemotherapy with CVP and Interferon-alfa2b (IFNα2b)

Jimena Cannata-Ortiz, MD, Concepción Nicolás, MD, Ana García-Noblejas, MD, Javier Lopez, Pilar Sabin, Pilar Zamora, Maria José Requena, Reyes Arranz, MD PhD
Journal: Blood
Blood (2014) 124 (21): 4465.
https://doi.org/10.1182/blood.V124.21.4465.4465
Published: 2014
Journal Articles

Manteinance Treatment with Interferon (IFN) Is Not Necessary to Achieve Prolonged Progression Free Survival (PFS) in Patients with Indolent Non Hodgkin’s Lymphoma (NHL). Results from a Prospective Randomized Trial on 165 Patients.

Jimena Cannata, Ph, Concepcion Nicolas, PhD, Raul Cordoba Resident, Ph, Consuelo Rayon, PhD, Jose Garcia-Laraña, PhD, Javier Lopez, Ph, Guillermo Perez, Ph, Pedro Sanchez-Godoy, PhD, Pilar Garcia-Alfonso, PhD, Pilar Zamora, Ph, Jose-Maria Fernandez-Rañada, PhD, Reyes Arranz, PhD
Journal: Blood
Blood (2004) 104 (11): 1392.
https://doi.org/10.1182/blood.V104.11.1392.1392
Published: 2004